Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-14-000356
Filing Date
2014-06-04
Accepted
2014-06-04 17:09:04
Documents
1
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxo-ther.html 4  
1 OWNERSHIP DOCUMENT glaxo-ther.xml 4 6955
  Complete submission text file 0000903423-14-000356.txt   8573
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 14891664
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations